PCM
SCR

Pentwater Capital Management’s SIMCERE PHARMACEUTICAL GROUP, ADS SCR Stock Holding History

Pentwater Capital Management’s Portfolio SCR Stock Details SCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-272,209
Closed -$2.58M – 101
2013
Q3 		$2.58M Buy
272,209
+19,536
+8% +$185K 0.07% 60
2013
Q2 		$2.4M Buy
+252,673
New +$2.4M 0.05% 58